Pharmacoeconomic evaluation of voriconazole vs. liposomal amphotericin B in empiric treatment of invasive fungal infections in Turkey حسب Turner, Stuart J.

"…There is a need to provide evidence of both clinical efficacy and value for money with any health technology. The current pharmacoeconomic evaluation investigated the use of liposomal amphotericin B (LAmB) and voriconazole for the empiric treatment of IFI in the Turkish setting.Methods: Decision analytic modelling was used to create a pathway for patient treatment with a 5-point composite outcome measure. …"
احصل على النص الكامل
احصل على النص الكامل